Related Experiment Video
Updated: Jul 15, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Interaction index and different methods for determining drug interaction in combination therapy.
1Department of Biostatistics, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA. jjlee@mdanderson.org
Journal of Biopharmaceutical Statistics
|May 5, 2007
Summary
This study enhances the analysis of drug interactions using the Loewe additivity model and Chou and Talalay
Area of Science:
- Pharmacology
- Drug Development
- Biostatistics
Background:
- Understanding combined treatment effects is crucial for developing effective combination therapies.
- The Loewe additivity model is a standard for evaluating drug interactions, defining synergy (index < 1) and antagonism (index > 1).
Purpose of the Study:
- To expand the interpretation of the interaction index within the Loewe additivity framework.
- To introduce a method for calculating the interaction index and confidence intervals, assuming Chou and Talalay's median effect equation for single agents.
- To review and compare four response surface models based on the Loewe additivity model for drug interaction assessment.
Main Methods:
- Proposed a procedure to calculate the interaction index and its confidence interval.
- Assumed dose-effect curves for single agents follow Chou and Talalay's median effect equation.
- Reviewed four response surface models derived from the Loewe additivity model.
Main Results:
- Developed an expanded method for calculating drug interaction indices and confidence intervals.
- Provided a comparative analysis of four response surface models based on the Loewe additivity principle.
Conclusions:
- The study offers a refined approach to quantifying drug interactions, integrating the Loewe additivity model with the median effect equation.
- Facilitates the practical application of drug interaction analysis through provided S-PLUS/R code.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Related Concept Videos
01:13Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...